About

Gador is a leading Argentine pharmaceutical company. For the last 82 years, its mission has been to investigate, develop, manufacture and commercialize the best quality medicines for every patient at affordable prices. Gador continuously invests in product technology and quality control, according to international standards and maintains a large updated portfolio of pharmaceutical products. Our company is currently focused on biopharmaceutics as a source of innovation and generation of new therapeutic resources for its territory, which is expanded throughout Latin America. Gador has a longstanding experience in the commercialization of special products, either own products or licenses from world renowned companies, such as Gilead Sciences Ltd, Astellas Pharma, Eli Lilly, Coherus, Viatris, MSD, Novartis, Cipla, among others. As a leader company in the market, Gador has undertaken an ambitious program in this area, which involves:  Licenses of new products approved or at their last clinical development stage  Commercialization of a new-generation biosimilar  Development and commercialization of new biopharmaceuticals with focus in special products and rare disease About Gador S.A. Gador is a leading Argentine pharmaceutical company. For the last 82 years, its mission has been to investigate, develop, manufacture and commercialize the best quality medicines for every patient at affordable prices. Gador continuously invests in product technology and quality control, according to international standards and maintains a large updated portfolio of pharmaceutical products. Our company is currently focused on biopharmaceutics as a source of innovation and generation of new therapeutic resources for its territory, which is expanded throughout Latin America. Gador has a longstanding experience in the commercialization of special products, either own products or licenses from world renowned companies, such as Gilead Sciences Ltd, Astellas Pharma, Eli Lilly, Coherus, Sifi, Recordati, Boehringer, Viatris, MSD, Novartis, among others. As a leader company in the market, Gador has undertaken an ambitious program in this area, which involves:  Licenses of new products approved or at their last clinical development stage  Commercialization of a new-generation biosimilar  Development and commercialization of new biopharmaceuticals with focus in special products and rare disease About Gador S.A. Gador is a leading Argentine pharmaceutical company. For the last 82 years, its mission has been to investigate, develop, manufacture and commercialize the best quality medicines for every patient at affordable prices. Gador continuously invests in product technology and quality control, according to international standards and maintains a large updated portfolio of pharmaceutical products. Our company is currently focused on biopharmaceutics as a source of innovation and generation of new therapeutic resources for its territory, which is expanded throughout Latin America. Gador has a longstanding experience in the commercialization of special products, either own products or licenses from world renowned companies, such as Gilead Sciences Ltd, Astellas Pharma, Eli Lilly, Coherus, Sifi, Recordati, Boehringer, Viatris, MSD, Novartis, among others. As a leader company in the market, Gador has undertaken an ambitious program in this area, which involves:  Licenses of new products approved or at their last clinical development stage  Commercialization of a new-generation biosimilar  Development and commercialization of new biopharmaceuticals with focus in special products and rare disease Gador is a leading pharmaceutical Company that investigate, develop, manufacture and commercialize medicinal products for human use. It is based in Argentina since 1940 and today covers the whole Latin America through own affiliates or a net of exclusive distributors. Gador continuously invests in product technology, quality control and new facilities development, according to international standards and approvals such as FDA, EMA, KFDA, COFEPRIS, TGA, among others.. Our company is currently focused on innovative therapies and products, such as biopharmaceutics, oligonucleotides and gene therapies as a source of generation of new therapeutic resources for its territory, which is expanded throughout Latin America. Gador has a long-standing experience in the commercialization of special and primary care products, either own products or licenses from world renowned companies, such as Gilead Sciences, Astellas, MSD, Boehringer Ingelheim, Recordati, Viatris, Sifi, Galderma, Besins, among others. As a leader company in the market, Gador has undertaken an ambitious program in this area, which involves:  Licenses of new products approved or at their last clinical development stage  Commercialization of a new-generation biosimilar  Development and commercialization of new biopharmaceuticals with focus in special products and rare disease In addition, Gador´s main shareholders have created a new development company: Qualix Dot (Design on Therapies). Qualix DoT is the research and development pharmaceutical company of Qualix Ventures.The purpose of Qualix DoT is to explore, drive, and collaborate in world-class innovative projects that come from academic or industrial initiatives by mainly repurposing known compounds for new indications. Qualix DoT adopts a collaborative business model whereby it works in partnership with academic, industrial and patients’ organizations. Biopharmaceuticals – rare disease – oncology – biosimilars – CAR T - Oligonucleotides y Repurposing